Jes Hathaway is the editor in chief of National Fisherman magazine and NationalFisherman.com.
Thursday, 16 June 2011
I am thrilled to hear today that the U.S. House is moving to bar genetically modified salmon before the Food and Drug Administration can approve it.
Alaska Rep. Don Young's amendment to a farm spending bill was approved by voice vote late Wednesday. And the House is expected to pass the bill this week. The amendment would prevent the FDA from spending money to approve the application from Massachusetts-based AquaBounty.
Despite pleas from many sectors, the FDA has appeared to be leaning toward approving the so-called Frankenfish (king salmon modified with a growth hormone that allows the fish to grow to market size in half the normal time) and has been considering whether it ought to be labeled as modified.
We have no idea what effect this biologically manipulated fish would have on wild species or the humans who might consume it. And the fact that the FDA is only considering whether or not to identify it with a label concerns me gravely.
If this fish were approved and went unlabeled, it could literally slip into the stream and leave consumers feeling even more insecure in their seafood consumption.
Tempting though it may be to look for easy answers to global food deficiencies, we ought not take the bait on this one.
National Fisherman Live: 11/06/14
In this episode:
NOAA report touts 2013 landings, value increases
Panama fines GM salmon company Aquabounty
Gulf council passes Reef Fish Amendment 40
Maine elver quota cut by 2,000 pounds
Offshore mussel farm would be East Coast’s first